These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

253 related items for PubMed ID: 19430402

  • 1. COX-2 expression in malignant melanoma: a novel prognostic marker?
    Becker MR, Siegelin MD, Rompel R, Enk AH, Gaiser T.
    Melanoma Res; 2009 Feb; 19(1):8-16. PubMed ID: 19430402
    [Abstract] [Full Text] [Related]

  • 2. Expression of CXCR4 predicts poor prognosis in patients with malignant melanoma.
    Scala S, Ottaiano A, Ascierto PA, Cavalli M, Simeone E, Giuliano P, Napolitano M, Franco R, Botti G, Castello G.
    Clin Cancer Res; 2005 Mar 01; 11(5):1835-41. PubMed ID: 15756007
    [Abstract] [Full Text] [Related]

  • 3. Prognostic value of COX-2 immunohistochemical expression evaluated by quantitative image analysis in colorectal cancer.
    Zafirellis K, Agrogiannis G, Zachaki A.
    APMIS; 2008 Oct 01; 116(10):912-22. PubMed ID: 19132985
    [Abstract] [Full Text] [Related]

  • 4. Expression of cyclooxygenase-2 in benign naevi and during human cutaneous melanoma progression.
    Kuźbicki L, Sarnecka A, Chwirot BW.
    Melanoma Res; 2006 Feb 01; 16(1):29-36. PubMed ID: 16432453
    [Abstract] [Full Text] [Related]

  • 5. Novel role for RGS1 in melanoma progression.
    Rangel J, Nosrati M, Leong SP, Haqq C, Miller JR, Sagebiel RW, Kashani-Sabet M.
    Am J Surg Pathol; 2008 Aug 01; 32(8):1207-12. PubMed ID: 18580492
    [Abstract] [Full Text] [Related]

  • 6. Identification of higher risk thin melanomas should be based on Breslow depth not Clark level IV.
    Owen SA, Sanders LL, Edwards LJ, Seigler HF, Tyler DS, Grichnik JM.
    Cancer; 2001 Mar 01; 91(5):983-91. PubMed ID: 11251950
    [Abstract] [Full Text] [Related]

  • 7. Prognostic significance of nuclear ING3 expression in human cutaneous melanoma.
    Wang Y, Dai DL, Martinka M, Li G.
    Clin Cancer Res; 2007 Jul 15; 13(14):4111-6. PubMed ID: 17634537
    [Abstract] [Full Text] [Related]

  • 8. Prognostic value of MMP-2 immunoreactive protein (72 kD type IV collagenase) in primary skin melanoma.
    Väisänen A, Kallioinen M, Taskinen PJ, Turpeenniemi-Hujanen T.
    J Pathol; 1998 Sep 15; 186(1):51-8. PubMed ID: 9875140
    [Abstract] [Full Text] [Related]

  • 9. Prognostic significance of activated Akt expression in melanoma: a clinicopathologic study of 292 cases.
    Dai DL, Martinka M, Li G.
    J Clin Oncol; 2005 Mar 01; 23(7):1473-82. PubMed ID: 15735123
    [Abstract] [Full Text] [Related]

  • 10. Cyclooxygenase-2 immunohistochemistry in human melanoma: differences between results obtained with different antibodies.
    Kuzbicki L, Lange D, Chwirot BW.
    Melanoma Res; 2009 Oct 01; 19(5):294-300. PubMed ID: 19543125
    [Abstract] [Full Text] [Related]

  • 11. Expression and prognostic role of MMP2, MMP9, MMP13, and MMP14 matrix metalloproteinases in sinonasal and oral malignant melanomas.
    Kondratiev S, Gnepp DR, Yakirevich E, Sabo E, Annino DJ, Rebeiz E, Laver NV.
    Hum Pathol; 2008 Mar 01; 39(3):337-43. PubMed ID: 18045645
    [Abstract] [Full Text] [Related]

  • 12. Increased expression of integrin-linked kinase is correlated with melanoma progression and poor patient survival.
    Dai DL, Makretsov N, Campos EI, Huang C, Zhou Y, Huntsman D, Martinka M, Li G.
    Clin Cancer Res; 2003 Oct 01; 9(12):4409-14. PubMed ID: 14555513
    [Abstract] [Full Text] [Related]

  • 13. The developmentally regulated neural crest-associated glycotope HNK-1 predicts metastasis in cutaneous malignant melanoma.
    Thies A, Schachner M, Berger J, Moll I, Schulze HJ, Brunner G, Schumacher U.
    J Pathol; 2004 Aug 01; 203(4):933-9. PubMed ID: 15258996
    [Abstract] [Full Text] [Related]

  • 14. Methylthioadenosine phosphorylase represents a predictive marker for response to adjuvant interferon therapy in patients with malignant melanoma.
    Meyer S, Wild PJ, Vogt T, Bataille F, Ehret C, Gantner S, Landthaler M, Klinkhammer-Schalke M, Hofstaedter F, Bosserhoff AK.
    Exp Dermatol; 2010 Aug 01; 19(8):e251-7. PubMed ID: 20500769
    [Abstract] [Full Text] [Related]

  • 15. Cyclooxygenase-2 (COX-2): first immunohistochemical marker distinguishing early cutaneous melanomas from benign melanocytic skin tumours.
    Chwirot BW, Kuźbicki Ł.
    Melanoma Res; 2007 Jun 01; 17(3):139-45. PubMed ID: 17505259
    [Abstract] [Full Text] [Related]

  • 16. Comparison of the prognostic value of matrix metalloproteinases 2 and 9 in cutaneous melanoma.
    Väisänen AH, Kallioinen M, Turpeenniemi-Hujanen T.
    Hum Pathol; 2008 Mar 01; 39(3):377-85. PubMed ID: 18187184
    [Abstract] [Full Text] [Related]

  • 17. Gene expression signatures for tumor progression, tumor subtype, and tumor thickness in laser-microdissected melanoma tissues.
    Jaeger J, Koczan D, Thiesen HJ, Ibrahim SM, Gross G, Spang R, Kunz M.
    Clin Cancer Res; 2007 Feb 01; 13(3):806-15. PubMed ID: 17289871
    [Abstract] [Full Text] [Related]

  • 18. Osteopontin as a molecular prognostic marker for melanoma.
    Rangel J, Nosrati M, Torabian S, Shaikh L, Leong SP, Haqq C, Miller JR, Sagebiel RW, Kashani-Sabet M.
    Cancer; 2008 Jan 01; 112(1):144-50. PubMed ID: 18023025
    [Abstract] [Full Text] [Related]

  • 19. Serological and immunohistochemical analysis of S100 and new derivatives as markers for prognosis in patients with malignant melanoma.
    Bolander A, Agnarsdóttir M, Wagenius G, Strömberg S, Pontén F, Ekman S, Brattström D, Larsson A, Einarsson R, Ullenhag G, Hesselius P, Bergqvist M.
    Melanoma Res; 2008 Dec 01; 18(6):412-9. PubMed ID: 19011512
    [Abstract] [Full Text] [Related]

  • 20. Cyclooxygenase-2 (Cox-2) expression and angiogenesis in glioblastoma.
    Onguru O, Gamsizkan M, Ulutin C, Gunhan O.
    Neuropathology; 2008 Feb 01; 28(1):29-34. PubMed ID: 18181832
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.